GNMLF (Genomma Lab InternacionalB de CV) Total Stockholders Equity : $543.0 Mil (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Genomma Lab InternacionalB de CV Total Stockholders Equity?

Genomma Lab InternacionalB de CV's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $543.0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Genomma Lab InternacionalB de CV's Book Value per Share for the quarter that ended in Mar. 2025 was $0.56. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Genomma Lab InternacionalB de CV's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.63.

Genomma Lab InternacionalB de CV Total Stockholders Equity Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Total Stockholders Equity Chart

Genomma Lab InternacionalB de CV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

444.52

490.99

520.75

552.76

521.91

Genomma Lab InternacionalB de CV Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															588.93	577.41	566.42	521.91	543.00

Genomma Lab InternacionalB de CV (OTCPK:GNMLF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Genomma Lab InternacionalB de CV's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(543.003	-	0)	/	973.793
	=	0.56

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Genomma Lab InternacionalB de CV's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(144.64	+	195.435)	/	543.003
	=	0.63

Genomma Lab InternacionalB de CV Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomma Lab InternacionalB de CV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (OTCPK:GNMLF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

LABB:Mexico GEKA:Germany

Address

Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210

Website

https://www.genommalab.com

Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.